Mobile Menu

Search Results

Search results for: Clinical Trials

Digitising clinical trials

A new perspective, published in npj Digital Medicine, has reviewed the status of digital clinical trials and described future priorities […]

COVID-19 clinical trials failing to enrol diverse populations

Despite global recognition that diversity within population studies is poor, clinical trials for current treatments and vaccines for COVID-19 still […]

Promises and pitfalls of precision medicine clinical trials, now and in the future

Availiable on demand here As we move towards an ever more personalised healthcare system, genomics is at the heart of […]

Talking simulated clinical trials with Ramon Hernandez, Sanofi

Ramon is head of RWE data and analytics. He works to turn the output of analytics models into business actions […]

Continuomics and the future of clinical trials

“No decision about me, without me” was to be the new standard of thinking for a more patient-centric NHS future, […]

COVID-19 pandemic and the rise of Complex Innovative Design trials

Complex Innovative Design (CID) trials have the potential to increase efficiency and lower the costs of drug development. This type […]

How do we increase diversity in clinical research?

Differences in genetics, physiology, race, ethnicity, age, and sex, as well as numerous other extrinsic factors, are known to affect […]

Machine Learning for Disruptive Drug Development – a 3 part webinar series

The cost of drug R&D has increased by ten-fold in the last 30 years, but the success rate of candidate […]

Interview with Anandbir Brar, Chief Executive Officer, Excelra

We recently interviewed Anandbir Brar, Chief Executive Officer of Excelra. Excelra is the lead sponsor for our D4 Global virtual event.  […]

An end to placebos?

Health data is changing. Now, big data promises to breathe new life into clinical trial design. So, does this mean […]